Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-136787
Filing Date
2024-12-16
Accepted
2024-12-16 18:00:49
Documents
1
Period of Report
2024-12-13

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 2905
  Complete submission text file 0000950170-24-136787.txt   4337
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Issuer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O RANI THERAPEUTICS HOLDINGS, INC. 2051 RINGWOOD AVE. SAN JOSE CA 95131
Business Address
McKinley Kate (Reporting) CIK: 0001979211 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40672 | Film No.: 241553062